Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes.
Saved in:
| Title: | Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes. |
|---|---|
| Authors: | Lim CE; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. carlemil.lim@ki.se., Pasternak B; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark., Eliasson B; Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden., Ueda P; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden. |
| Source: | Diabetologia [Diabetologia] 2025 Aug; Vol. 68 (8), pp. 1680-1695. Date of Electronic Publication: 2025 May 02. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0428 (Electronic) Linking ISSN: 0012186X NLM ISO Abbreviation: Diabetologia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
